Ledger.Open graph →
SEC Form D · filed August 30, 2013

Syndax Pharmaceuticals Inc

Offering
$48.4M
Sold
$31.3M
Exemption
—
Industry
Pharmaceuticals
Location
WALTHAM, MA
Type
—

People & firms on this filing (5)

Richard C. Temme · Woodland Hills, CADirectorRichard G. Chyette · Livonia, MIDirectorStephen G. Greenberg · New York, NYExec · DirectorKim Kamdar, Ph.D · Waltham, MADirectorFabrice Egros · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗